Medicure (MCUJF) Gains from Sales and Divestitures (2017)
Medicure's (MCUJF) quarterly Gains from Sales and Divestitures came in at -$9.4 million in Q3 2017, down 95.2% quarter-over-quarter from -$4.8 million in Q2 2017.
Medicure (MCUJF) Gains from Sales and Divestitures (2017) Analysis & Trends
Medicure's Gains from Sales and Divestitures history runs 1 years deep, the most recent figure standing at -$9.4 million for Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -9.42 Mn |
| Sep 30, 2017 | -9.42 Mn |
| Jun 30, 2017 | -4.83 Mn |
| Jun 30, 2017 | -4.83 Mn |
| Mar 31, 2017 | -4.73 Mn |
| Mar 31, 2017 | -4.73 Mn |